Skip to main navigation
  • Contact Us
Path 31
  • Our Team
  • Investors & Media
    • Overview
    • News and Events
    • Corporate Governance
    • Stock Information
    • Financials and Filings
    • Resources
  • Contact Us
Follow us

Investors & Media Press Releases


Data Provided by Refinitiv.
Minimum 15 minutes delayed.

Learn More
  • Press Releases
  • IR Events & Presentations
  • Medical Events & Publications
Nov 21, 2022
Graybug and CalciMedica Enter into Definitive Merger Agreement
Nov 10, 2022
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
Aug 11, 2022
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
Jul 06, 2022
Graybug to Present at the 2022 OIS Retina Innovation Summit
Jun 28, 2022
Graybug Announces Review of Strategic Alternatives
May 19, 2022
Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting
May 10, 2022
Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments
Apr 27, 2022
Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting
Apr 18, 2022
Graybug to Present at the 2022 ASCRS Annual Meeting
Apr 13, 2022
Graybug Vision Appoints Dirk Sauer to Board of Directors
Pagination
  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 15

Graybug Vision, Inc.
Phone: (650)-487-2800
info@graybug.vision
IR@graybug.vision
media@graybug.vision
Our team Management Board of directors Contact Us Follow Us
Investors and media Overview News and events Corporate governance Stock information Financials and filings Resources
© 2023 Graybug Vision, Inc. | Privacy Policy